I, l , 3-trioxo-l , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors

Details for Australian Patent Application No. 2006321904 (hide)

International Classifications

Event Publications

26 June 2008 PCT application entered the National Phase

PCT publication WO2007/067614 Priority application(s): WO2007/067614

17 July 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Novartis AG, Application No. 2006321904, under INID (54) correct the title to read 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTPases inhibitors

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.